HESPECTA: Phase I/II started

ISA said investigators began an open-label, dose-escalation, Dutch Phase

Read the full 97 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE